From Standardization to Adaptation: Clinical Trials and the Moral Economy of Anticipation

References

• Adam, B. (2004) Time (Cambridge: Polity Press).
   Google Scholar
• Adams, V., Murphy, M. and Clark, A. E. (2009) Anticipation: Technoscience, life, affect, temporality, Subjectivity, 28, pp. 246–265. doi: 10.1057/sub.2009.18
   Google Scholar
• Adebamowo, C., Bah-Sow, O., Binka, F., Bruzzone, R., Caplan, A., Delfraissy, J.-F., Heymann, D., Horby, P., Kaleebu, P., Tamfum, J.-J. M., Olliaro, P., Piot, P., Tejan-Cole, A., Tomori, O., Toure, A., Torreele, E. and Whitehead, J. (2014) Randomised controlled trials for Ebola: Practical and ethical issues, The Lancet, 384(9952), pp. 1423–1424. doi: 10.1016/S0140-6736(14)61734-7
   PubMed Web of Science ®Google Scholar
• Anscombe, F. J. (1963) Sequential medical trials, Journal of the American Statistical Association, 58, pp. 365–383. doi: 10.1080/01621459.1963.10500851
   Web of Science ®Google Scholar
• Armstrong, D. (2002) A New History of Identity. A Sociology of Medical Knowledge (Basingstoke: Palgrave).
   Google Scholar
• Armstrong, D. (2012) Screening: Mapping medicine’s temporal spaces, Sociology of Health & Illness, 34(2), pp. 177–193. doi: 10.1111/j.1467-9566.2011.01438.x
   PubMed Web of Science ®Google Scholar
• Armstrong, D. (2014) Chronic illness: A revisionist account, Sociology of Health & Illness, 36(1), pp. 15–27. doi: 10.1111/1467-9566.12037
   PubMed Web of Science ®Google Scholar
• Barker, A. D., Sigman, C. C., Kelloff, G. J., Hylton, N. M., Berry, D. A. and Esserman, L. J. (2009) I-SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy, Clinical Pharmacology & Therapeutics, 86(1), pp. 97–100. doi: 10.1038/clpt.2009.68
   PubMed Web of Science ®Google Scholar
• Bartlett, R. H. (2014) Clinical research in acute fatal illness: Lessons from extracorporeal membrane oxygenation, Journal of Intensive Care Medicine, 31(7), pp. 456–465. doi: 10.1177/0885066614550278
   PubMed Web of Science ®Google Scholar
• Bartlett, R. H., Roloff, D. W., Cornell, R. G., Andrews, A. F., Dillon, P. W. and Zwischenberger, J. B. (1985) Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study, Pediatrics, 76(4), pp. 479–487.
   PubMed Web of Science ®Google Scholar
• Berg, M. (1997) Rationalizing Medical Work: Decision Support Techniques and Medical Practices (Cambridge, MA: MIT Press).
   Google Scholar
• Berry, D. (2006) Bayesian clinical trials, Nature Reviews Drug Discovery, 5, pp. 27–36. doi: 10.1038/nrd1927
   PubMed Web of Science ®Google Scholar
• Berry, S. M., Petzold, E. A., Dull, P., Thielman, N. M., Cunningham, C. K., Corey, G. R., McClain, M. T., Hoover, D. L., Russell, J., Griffiss, J. M. and Woods, C. W. (2016) A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response, Clinical Trials, 13(1), pp. 22–30. doi: 10.1177/1740774515621721
   PubMed Web of Science ®Google Scholar
• Bornkamp, B., Bretz, F., Dmitrienko, A., Enas, G., Gaydos, B., Hsu, C., Konig, F., Krams, M., Liu, Q., Neuenschwander, B., Parke, T., Pinheiro, J., Roy, A., Sax, R. and Shen, F. (2007) Innovative approaches for designing and analyzing adaptive dose-ranging trials, Journal of Biopharmaceutical Statistics, 17, pp. 965–995. doi: 10.1080/10543400701643848
   PubMed Web of Science ®Google Scholar
• Bosely, S. (2015) Ebola: The race to find a cure, The Guardian, February 17.
   Google Scholar
• Chuang-Stein, C., Bretz, F., Komiyama, O. and Quinlan, J. (2009) Interactions with regulatory agencies to enhance the understanding and acceptance of adaptive designs, Regulatory Focus, 14(4), pp. 36–42.
   Google Scholar
• Colton, T. (1963) A model for selecting one of two medical treatments, Journal of the American Statistical Association, 58, pp. 388–400. doi: 10.1080/01621459.1963.10500853
   Web of Science ®Google Scholar
• Cox, E., Borio, L. and Temple, R. (2014) Evaluating Ebola therapies—The case for RCTS, New England Journal of Medicine, 371(25), pp. 2350–2351. doi: 10.1056/NEJMp1414145
   PubMed Web of Science ®Google Scholar
• Cytel (no date) Cytel Adaptive Case Study 1. Available at http://www.cytel.com/hubfs/0-library-0/cases/case-1-medical-science-adaptive-cardiovascular-trial.pdf (accessed 22 June 2015).
   Google Scholar
• Davis, C. and Abraham, J. (2013) Unhealthy Pharmaceutical Regulation. Innovation, Politics and Promissory Science (Basingstoke: Palgrave Macmillan).
   Google Scholar
• DeVita, V. T. (2008) The clinical trials system is broken, Nature Clinical Practice Oncology, 5(12), pp. 683–683. doi: 10.1038/ncponc1263
   PubMedGoogle Scholar
• Elliott, S. J. (1991) Neonatal extracorporeal membrane oxygenation: How not to assess novel technologies, The Lancet, 337(8739), pp. 476–478. doi: 10.1016/0140-6736(91)93406-Y
   PubMed Web of Science ®Google Scholar
• FDA (2004) Innovation or Stagnation?—Challenge and Opportunity on the Critical Path to New Medical Products (Silver Spring: U.S. Food and Drug Administration).
   Google Scholar
• FDA (2006) Critical Path Opportunities List (Silver Spring: U.S. Food and Drug Administration).
   Google Scholar
• Fisher, J. A. (2009) Medical Research for Hire. The Political Economy of Pharmaceutical Clinical Trials (New Brunswick, NJ: Rutgers University Press).
   Google Scholar
• Freudenberg, N. (2014) Lethal But Legal: Corporations, Consumption, and Protecting Public Health (Oxford: Oxford University Press).
   Google Scholar
• Gallo, P. and Krams, M. (2006) PhRMA working group on adaptive designs: Introduction to the full white paper, Drug Information Journal, 40(4), pp. 421–423.
   Google Scholar
• Giovagnoli, A. and Zagoraiou, M. (2012) Simulation of clinical trials: A review with emphasis on the design issues, Statistica, LXXII(1), pp. 63–80.
   Google Scholar
• Hayden, E. C. (2014) Ethical dilemma for Ebola trials, Nature, 515, pp. 177–178. doi: 10.1038/515177a
   PubMed Web of Science ®Google Scholar
• Holford, N. H. G., Kimko, H. C., Monteleone, J. P. R. and Peck, C. C. (2000) Simulation of clinical trials, Annual Review of Pharmacology and Toxicology, 40, pp. 209–234. doi:10.1146/annurev.pharmtox.40.1.209
   PubMed Web of Science ®Google Scholar
• Holford, N., Ma, S. C. and Ploeger, B. A. (2010) Clinical trial simulation: A review, Clinical Pharmacology & Therapeutics, 88(2), pp. 166–182. doi: 10.1038/clpt.2010.114
   PubMed Web of Science ®Google Scholar
• Hutson, S. (2009) A change is in the wind as ‘adaptive’ clinical trials catch on, Nature Medicine, 15(9), p. 977. doi: 10.1038/nm0909-977
   PubMed Web of Science ®Google Scholar
• Joffe, S. (2014) Evaluating novel therapies during the Ebola epidemic, Journal of the American Medical Association, 312(13), pp. 1299–1300. doi: 10.1001/jama.2014.12867
   PubMed Web of Science ®Google Scholar
• Jones, D. (2010) Adaptive trials receive boost, Nature Reviews Drug Discovery, 9(5), pp. 345–348. doi: 10.1038/nrd3174
   PubMed Web of Science ®Google Scholar
• Kanters, S., Thorlund, K. and Mills, E. J. (2015) Ethical testing of experimental Ebola treatments—Reply, Journal of the American Medical Association, 313(4), pp. 421–422. doi: 10.1001/jama.2014.17259
   Web of Science ®Google Scholar
• Knox, R. A. (1989) A Harvard study on newborns draws lire: Doctor faulted for limiting lifesaving therapy, Boston Globe, pp. 25–27.
   Google Scholar
• Krams, M., Lees, K. R. and Berry, D. A. (2005) The past is the future. Innovative designs in acute stroke therapy trials, Stroke, 36, pp. 1341–1347. doi: 10.1161/01.STR.0000165931.77045.ee
   PubMed Web of Science ®Google Scholar
• Lang, T. (2011) Adaptive trial design: Could we use this approach to improve clinical trials in the field of global health? American Journal of Tropical Medicine and Hygiene, 85(6), pp. 967–970. doi:10.4269/ajtmh.2011.11-0151
   PubMed Web of Science ®Google Scholar
• Lantos, J. D. and Frader, J. (1990) Extracorporeal membrane oxygenation and the ethics of clinical research in pediatrics, New England Journal of Medicine, 323(6), pp. 409–413. doi: 10.1056/NEJM199008093230610
   PubMed Web of Science ®Google Scholar
• Lewis, R., Viele, K., Broglio, K., Berry, S. and Jones, A. (2013) An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predicted probability of subsequent phase III success, Critical Care Medicine, 41(7), pp. 1674–1678. doi: 10.1097/CCM.0b013e318287f850
   PubMed Web of Science ®Google Scholar
• Lezaun, J. and Montgomery, C. M. (2015) The pharmaceutical commons: Sharing and exclusion in global health drug development, Science, Technology & Human Values, 40(1), pp. 3–29. doi: 10.1177/0162243914542349
   PubMed Web of Science ®Google Scholar
• Malcontent (1997) Fumes from the spleen, Pediatric and Perinatal Epidemiology, 11, pp. 260–264. doi: 10.1111/j.1365-3016.1997.tb00002.x
   PubMedGoogle Scholar
• Maloney, A., Karlsson, M. O. and Simonsson, U. S. H. (2007) Optimal adaptive design in clinical drug development: A simulation example, The Journal of Clinical Pharmacology, 47(10), pp. 1231–1243. doi: 10.1177/0091270007308033
   PubMed Web of Science ®Google Scholar
• Miké, V., Krauss, A. N. and Gail, S. (1993) Neonatal extracorporeal membrane oxygenation (ECMO): Clinical trials and the ethics of evidence, Journal of Medical Ethics, 19(4), pp. 212–218. doi: 10.1136/jme.19.4.212
   PubMed Web of Science ®Google Scholar
• O’Rourke, P. P., Crone, R. K., Vacanti, J. P., Ware, J. H., Lillehei, C. W., Parad, R. B. and Epstein, M. F. (1989) Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study, Pediatrics, 84(6), pp. 957–963.
   PubMed Web of Science ®Google Scholar
• Petryna, A. (2009) When Experiments Travel. Clinical Trials and the Global Search for Human Subjects (Princeton, NJ: Princeton University Press).
   Google Scholar
• Pocock, S. J. (1979) Allocation of patients to treatment in clinical trials, Biometrics, 35(1), pp. 183–197. doi: 10.2307/2529944
   PubMed Web of Science ®Google Scholar
• Rose, N. (2001) The Politics of Life Itself, Theory, Culture and Society, 18(6), pp. 1–30. doi: 10.1177/02632760122052020
   Web of Science ®Google Scholar
• Rose, N. (2007) The Politics of Life Itself: Biomedicine, Power and Subjectivity in the Twenty-First Century (Princeton, NJ: Princeton University Press).
   Google Scholar
• Salman, R. A., Beller, E., Kagan, J., Hemminki, E., Phillips, R. S., Savulescu, J., Macleod, M., Wisely, J. and Iain, C. (2014) Increasing value and reducing waste in biomedical research regulation and management, The Lancet, 383, pp. 176–185. doi: 10.1016/S0140-6736(13)62297-7
   PubMed Web of Science ®Google Scholar
• Simon, R. (1977) Adaptive treatment assignment methods and clinical trials, Biometrics, 33(4), pp. 743–749. doi: 10.2307/2529473
   PubMed Web of Science ®Google Scholar
• SMi (2014) Adaptive Designs in Clinical Trials 24th & 25th March 2014, London, Conference Information Pack.
   Google Scholar
• Soll, R. F. (1996) Neonatal extracorporeal membrane oxygenation-bridging technique, The Lancet, 348(9020), pp. 70–71. doi: 10.1016/S0140-6736(05)64602-8
   PubMed Web of Science ®Google Scholar
• Sunder Rajan, K. (2006) Biocapital: The Constitution of Postgenomic Life (Durham, NC: Duke University Press).
   Google Scholar
• Sunder Rajan, K. (2007) Experimental values: Indian clinical trials and surplus health, New Left Review, 45, pp. 67–88.
   Google Scholar
• Thomas, L. (2014) Pandemics of the future: Disease surveillance in real time, Surveillance & Society, 12(2), pp. 287–300.
   Google Scholar
• Thompson, W. R. (1933) On the likelihood that one unknown probability exceeds another in view of the evidence of two samples, Biometrika, 25, pp. 285–294. doi: 10.1093/biomet/25.3-4.285
   Google Scholar
• Timmermans, S. and Berg, M. (1997) Standardization in action: Achieving local universality through medical protocols, Social Studies of Science, 27(2), pp. 273–305. doi: 10.1177/030631297027002003
   Web of Science ®Google Scholar
• Timmermans, S. and Berg, M. (2003) The gold standard. The challenge of evidence-based medicine and standardization in health care (Philadelphia, PA: Temple University Press).
   Google Scholar
• Tutton, R. (2012) Personalizing medicine: Futures present and past, Social Science & Medicine, 75, pp. 1721–1728. doi: 10.1016/j.socscimed.2012.07.031
   PubMed Web of Science ®Google Scholar
• Unguru, Y. (2011) The successful integration of research and care: How pediatric oncology became the subspecialty in which research defines the standard of care, Pediatric Blood Cancer, 56, pp. 1019–1025. doi: 10.1002/pbc.22976
   PubMed Web of Science ®Google Scholar
• Vickers, A. J. (2014) Clinical trials in crisis: Four simple methodologic fixes, Clinical Trials, 11(6), pp. 615–621.
   Google Scholar
• Waldby, C. (2000) The Visible Human Project (London: Routledge).
   Google Scholar
• Waldby, C. (2002) Stem cells, tissue cultures and the production of biovalue, Health: An Interdisciplinary Journal, 6(3), pp. 305–323. doi: 10.1177/136345930200600304
   Web of Science ®Google Scholar
• Wallace, M. P. and Moodie, E. E. (2014) Personalizing medicine: A review of adaptive treatment strategies, Pharmacoepidemiology and Drug Safety, 23(6), pp. 580–585. doi: 10.1002/pds.3606
   PubMed Web of Science ®Google Scholar
• Weinstein, M. C. (1974) Allocation of Subjects in medical experiments, New England Journal of Medicine, 291, pp. 1278–1285. doi: 10.1056/NEJM197412122912405
   PubMed Web of Science ®Google Scholar
• Whitehead, J., Olliaro, P., Lang, T. and Horby, P. (2016) Trial design for evaluating novel treatments during an outbreak of an infectious disease, Clinical Trials, 13(1), pp. 31–38. doi: 10.1177/1740774515617740
   PubMed Web of Science ®Google Scholar
• Woodcock, J. and Woosley, R. (2008) The FDA critical path initiative and its influence on new drug development, Annual Review of Medicine, 59, pp. 1–12. doi:10.1146/annurev.med.59.090506.155819
   PubMed Web of Science ®Google Scholar
• Zelen, M. (1969) Play the winner rule and the controlled clinical trial, Journal of the American Statistical Association, 64(325), pp. 131–146. doi: 10.1080/01621459.1969.10500959
   Web of Science ®Google Scholar